Vision loss can have significant effects on your daily life. You don’t need to be legally blind to qualify for certain disability benefits and support. Share on Pinterest SeventyFour/Getty Images ...

Bret Baier highlights a groundbreaking clinical trial targeting age-related vision loss using gene therapy. The treatment ...

In 2019, 57 million people worldwide were living with dementia, a figure expected to soar to 153 million by 2050. A recent Lancet Commission report suggests that nearly half of dementia cases could be ...

Revolutionary devices, age rewinding, and cell regeneration: scientists are finding multiple promising approaches for curing ...

CRISPR gene editing is a genetic technique that removes mutated genes and replaces them with nonmutated ones. While some research indicates it may help with vision, there is no conclusive evidence.

Glaucoma is often called the "silent thief of sight" because it can gradually damage vision for years before noticeable ...

The new study, undertaken by researchers at Oregon Health & Science University and published by Jama Ophthalmology, suggests that GLP-1 drugs such as Ozempic and Monjaro can reduce the risk of ...

As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...

Raised blood sugar levels due to diabetes may damage blood vessels and organs, leading to complications such as vision loss. Some ways to cope include getting support from a low vision specialist and ...

Losing vision can be overwhelming and scary. For many, it comes with an unexpected side effect—hallucinations. Charles Bonnet Syndrome (CBS) causes vivid visual experiences in people with vision loss, ...

Many animals, including humans, rely on their eyes to detect changes in their surroundings. The eyes of vertebrates, animals with a backbone or a similar supporting structure, contain a transparent ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...